Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis [NA]

View source ↗

Summary

A completed clinical trial investigates how fractionated dosing of testosterone cypionate affects erythrocytosis in transgender men. The trial is sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone cypionate (testosterone cypionate)

Snippet

Sponsor: University of Sao Paulo | Conditions: Testosterone, Transsexualism | NA | Status: COMPLETED